InvestorsHub Logo
Replies to #72422 on Biotech Values

genisi

01/30/09 4:53 AM

#72431 RE: DewDiligence #72422

Agree that a statin/fenofibrate co-formulation holds great potential, especially with the cloud over CETP inhibitor class.